RecruitingNot ApplicableNCT06824688

Single-port Versus Multi-port Robotic Surgery for Rectal Cancer

Efficacy and Safety Assessment of Single-port Versus Multi-port Robotic Surgery for Rectal Cancer: a Phase 2 Non-randomized Controlled Study Based on the IDEAL Framework


Sponsor

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

Enrollment

40 participants

Start Date

Apr 26, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Single-port versus multi-port robotic surgery for rectal cancer


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Multi-port robotic total mesorectal excision and a procedure called Single-port robotic total mesorectal excision for people with rectal cancer patients and robotic surgical procedures. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURESingle-port robotic total mesorectal excision

Single-port robotic total mesorectal excision

PROCEDUREMulti-port robotic total mesorectal excision

Multi-port robotic total mesorectal excision


Locations(1)

Huichao Zheng

Chongqing, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06824688


Related Trials